SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-030288
Filing Date
2024-08-05
Accepted
2024-08-05 17:15:11
Documents
15
Period of Report
2024-07-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52077
2 ex16-1.htm EX-16.1 6106
  Complete submission text file 0001493152-24-030288.txt   281134

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20240731.xsd EX-101.SCH 3892
4 XBRL DEFINITION FILE celu-20240731_def.xml EX-101.DEF 26799
5 XBRL LABEL FILE celu-20240731_lab.xml EX-101.LAB 37063
6 XBRL PRESENTATION FILE celu-20240731_pre.xml EX-101.PRE 25423
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6064
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 241176026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)